Videos de Experimentos Relacionados
Úlceras orales de larga duración.
Carolina Talhari1, Wolfgang Angerstein, Jürgen Becker
1Department of Dermatology, Faculty of Medicine, Heinrich-Heine-University, 40225 Düsseldorf, Germany.
Lancet (London, England)
|March 16, 2005
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Tumor-like periungual cutaneous sporotrichosis in an endemic area.
Anais brasileiros de dermatologia·2026
Same author
The Scaffold Protein Liprin β-1 (PPFIBP1) and the Intermediate Filament Synemin: Potential New Markers of Lymphatic Endothelial Cells.
Cells·2026
Same author
Syndromic management of sexually transmitted infections in the Brazilian Amazon: A 10-year retrospective study.
PLoS neglected tropical diseases·2026
Same author
[Corrigendum] Tumor necrosis factor‑α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial‑ and non‑mitochondrial‑dependent pathways.
International journal of oncology·2026
Same author
Diagnostic performance of peripheral nerve palpation compared with ultrasonography in leprosy neuropathy: A prospective real-world clinical evaluation.
PLoS neglected tropical diseases·2026
Same author
Implementation of ML Flow for leprosy contacts in Brazil: Opportunities, pitfalls, and safeguards.
PLoS neglected tropical diseases·2026
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026